Email This Article

Headlines & Perspectives
Feuerstein's Biotech-Stock Mailbag
By Adam Feuerstein
05/03/08 - 11:10 AM EDT
Outlooks for SuperGen's Dacogen and Myriad Genetics' Flurizan; more Q&A on ImClone's Erbitux, and more.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)

Privacy Policy

The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.

Dow Jones S&P 500 NASDAQ 10-Year Note
10,309.92 1,091.49 2,138.44 32.38
Oil *
76.52
DOWN
154.48
DOWN
19.14
DOWN
37.61
UP
0.07
10 Yr
3.24%
SPDR Gold
115.06
-1.48%
-1.72%
-1.73%
+0.22%
Data delayed 20 minutes

Brokerage Partners